Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05023473Completed
Randomised, open-label trial (2 arms), sponsored by Suez Canal University. Primary endpoint: Morphine consumption at 24 hours. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05023473.